Global Advanced Therapeutics Pharmaceutical Outsourcing Market 2026 by Company, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Advanced Therapeutics Pharmaceutical Outsourcing by Type
- 1.3.1 Overview: Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value Market Share by Type in 2025
- 1.3.3 Contract Research Organizations (CROs)
- 1.3.4 Contract Development and Manufacturing Organizations (CDMOs)
- 1.4 Global Advanced Therapeutics Pharmaceutical Outsourcing Market by Application
- 1.4.1 Overview: Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Preclinical Services
- 1.4.3 Clinical Services
- 1.4.4 Commercial Manufacturing and Packaging
- 1.5 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecast
- 1.6 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast by Region
- 1.6.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region, (2021-2032)
- 1.6.3 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Prospect (2021-2032)
- 1.6.4 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Prospect (2021-2032)
- 1.6.6 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Croda International Plc
- 2.1.1 Croda International Plc Details
- 2.1.2 Croda International Plc Major Business
- 2.1.3 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.1.4 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Croda International Plc Recent Developments and Future Plans
- 2.2 Charles River Laboratories International, Inc.
- 2.2.1 Charles River Laboratories International, Inc. Details
- 2.2.2 Charles River Laboratories International, Inc. Major Business
- 2.2.3 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.2.4 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Charles River Laboratories International, Inc. Recent Developments and Future Plans
- 2.3 Catalent, Inc.
- 2.3.1 Catalent, Inc. Details
- 2.3.2 Catalent, Inc. Major Business
- 2.3.3 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.3.4 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Catalent, Inc. Recent Developments and Future Plans
- 2.4 QuintileslMS (IQVIA)
- 2.4.1 QuintileslMS (IQVIA) Details
- 2.4.2 QuintileslMS (IQVIA) Major Business
- 2.4.3 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.4.4 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 QuintileslMS (IQVIA) Recent Developments and Future Plans
- 2.5 Parexel International Corporation
- 2.5.1 Parexel International Corporation Details
- 2.5.2 Parexel International Corporation Major Business
- 2.5.3 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.5.4 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Parexel International Corporation Recent Developments and Future Plans
- 2.6 ICON plc
- 2.6.1 ICON plc Details
- 2.6.2 ICON plc Major Business
- 2.6.3 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.6.4 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 ICON plc Recent Developments and Future Plans
- 2.7 PPD, Inc. (Thermo Fisher Scientific)
- 2.7.1 PPD, Inc. (Thermo Fisher Scientific) Details
- 2.7.2 PPD, Inc. (Thermo Fisher Scientific) Major Business
- 2.7.3 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.7.4 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 PPD, Inc. (Thermo Fisher Scientific) Recent Developments and Future Plans
- 2.8 LabCorp (Laboratory Corporation of America Holdings)
- 2.8.1 LabCorp (Laboratory Corporation of America Holdings) Details
- 2.8.2 LabCorp (Laboratory Corporation of America Holdings) Major Business
- 2.8.3 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.8.4 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 LabCorp (Laboratory Corporation of America Holdings) Recent Developments and Future Plans
- 2.9 Syneos Health
- 2.9.1 Syneos Health Details
- 2.9.2 Syneos Health Major Business
- 2.9.3 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.9.4 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Syneos Health Recent Developments and Future Plans
- 2.10 wuXi AppTecLonza Group
- 2.10.1 wuXi AppTecLonza Group Details
- 2.10.2 wuXi AppTecLonza Group Major Business
- 2.10.3 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.10.4 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 wuXi AppTecLonza Group Recent Developments and Future Plans
- 2.11 Piramal Pharma Solutions
- 2.11.1 Piramal Pharma Solutions Details
- 2.11.2 Piramal Pharma Solutions Major Business
- 2.11.3 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.11.4 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Piramal Pharma Solutions Recent Developments and Future Plans
- 2.12 SGS SA
- 2.12.1 SGS SA Details
- 2.12.2 SGS SA Major Business
- 2.12.3 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.12.4 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 SGS SA Recent Developments and Future Plans
- 2.13 Evotec SE
- 2.13.1 Evotec SE Details
- 2.13.2 Evotec SE Major Business
- 2.13.3 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.13.4 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Evotec SE Recent Developments and Future Plans
- 2.14 CMC Biologics (Now AGC Biologics)
- 2.14.1 CMC Biologics (Now AGC Biologics) Details
- 2.14.2 CMC Biologics (Now AGC Biologics) Major Business
- 2.14.3 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.14.4 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 CMC Biologics (Now AGC Biologics) Recent Developments and Future Plans
- 2.15 Marken (A UPS Company)
- 2.15.1 Marken (A UPS Company) Details
- 2.15.2 Marken (A UPS Company) Major Business
- 2.15.3 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.15.4 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Marken (A UPS Company) Recent Developments and Future Plans
- 2.16 Cytovance Biologics
- 2.16.1 Cytovance Biologics Details
- 2.16.2 Cytovance Biologics Major Business
- 2.16.3 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.16.4 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 Cytovance Biologics Recent Developments and Future Plans
- 2.17 Samsung Biologics
- 2.17.1 Samsung Biologics Details
- 2.17.2 Samsung Biologics Major Business
- 2.17.3 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product and Solutions
- 2.17.4 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Gross Margin and Market Share (2021-2026)
- 2.17.5 Samsung Biologics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Advanced Therapeutics Pharmaceutical Outsourcing by Company Revenue
- 3.2.2 Top 3 Advanced Therapeutics Pharmaceutical Outsourcing Players Market Share in 2025
- 3.2.3 Top 6 Advanced Therapeutics Pharmaceutical Outsourcing Players Market Share in 2025
- 3.3 Advanced Therapeutics Pharmaceutical Outsourcing Market: Overall Company Footprint Analysis
- 3.3.1 Advanced Therapeutics Pharmaceutical Outsourcing Market: Region Footprint
- 3.3.2 Advanced Therapeutics Pharmaceutical Outsourcing Market: Company Product Type Footprint
- 3.3.3 Advanced Therapeutics Pharmaceutical Outsourcing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Type (2021-2032)
- 6.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Application (2021-2032)
- 6.3 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country
- 6.3.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Country (2021-2032)
- 6.3.2 United States Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 6.3.3 Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Type (2021-2032)
- 7.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Application (2021-2032)
- 7.3 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country
- 7.3.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Country (2021-2032)
- 7.3.2 Germany Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 7.3.3 France Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 7.3.5 Russia Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 7.3.6 Italy Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region
- 8.3.1 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Region (2021-2032)
- 8.3.2 China Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 8.3.3 Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 8.3.5 India Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 8.3.7 Australia Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Type (2021-2032)
- 9.2 South America Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Application (2021-2032)
- 9.3 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country
- 9.3.1 South America Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country
- 10.3.1 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
- 10.3.4 UAE Advanced Therapeutics Pharmaceutical Outsourcing Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Advanced Therapeutics Pharmaceutical Outsourcing Market Drivers
- 11.2 Advanced Therapeutics Pharmaceutical Outsourcing Market Restraints
- 11.3 Advanced Therapeutics Pharmaceutical Outsourcing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Advanced Therapeutics Pharmaceutical Outsourcing Industry Chain
- 12.2 Advanced Therapeutics Pharmaceutical Outsourcing Upstream Analysis
- 12.3 Advanced Therapeutics Pharmaceutical Outsourcing Midstream Analysis
- 12.4 Advanced Therapeutics Pharmaceutical Outsourcing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Advanced Therapeutics Pharmaceutical Outsourcing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Advanced Therapeutics Pharmaceutical Outsourcing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Advanced Therapeutics Pharmaceutical Outsourcing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Advanced Therapeutics Pharmaceutical Outsourcing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Advanced Therapeutics Pharmaceutical Outsourcing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Advanced Therapeutics Pharmaceutical Outsourcing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Advanced Therapeutics Pharmaceutical Outsourcing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Advanced Therapeutics Pharmaceutical Outsourcing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Croda International Plc, Charles River Laboratories International, Inc., Catalent, Inc., QuintileslMS (IQVIA), Parexel International Corporation, ICON plc, PPD, Inc. (Thermo Fisher Scientific), LabCorp (Laboratory Corporation of America Holdings), Syneos Health, wuXi AppTecLonza Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Advanced Therapeutics Pharmaceutical Outsourcing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
Market segment by Application
Preclinical Services
Clinical Services
Commercial Manufacturing and Packaging
Market segment by players, this report covers
Croda International Plc
Charles River Laboratories International, Inc.
Catalent, Inc.
QuintileslMS (IQVIA)
Parexel International Corporation
ICON plc
PPD, Inc. (Thermo Fisher Scientific)
LabCorp (Laboratory Corporation of America Holdings)
Syneos Health
wuXi AppTecLonza Group
Piramal Pharma Solutions
SGS SA
Evotec SE
CMC Biologics (Now AGC Biologics)
Marken (A UPS Company)
Cytovance Biologics
Samsung Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Advanced Therapeutics Pharmaceutical Outsourcing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Advanced Therapeutics Pharmaceutical Outsourcing, with revenue, gross margin, and global market share of Advanced Therapeutics Pharmaceutical Outsourcing from 2021 to 2026.
Chapter 3, the Advanced Therapeutics Pharmaceutical Outsourcing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Advanced Therapeutics Pharmaceutical Outsourcing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Advanced Therapeutics Pharmaceutical Outsourcing.
Chapter 13, to describe Advanced Therapeutics Pharmaceutical Outsourcing research findings and conclusion.